• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Pharmacokinetic characteristics of streptomycin and isoniazid administered in ultrasonic aerosols to patients with respiratory organ tuberculosis].

作者信息

Brant A L, Semenova E A

出版信息

Antibiotiki. 1981 Aug;26(8):628-32.

PMID:7294755
Abstract

The study on the pharmacokinetics of streptomycin and isoniazid (2012 assays of the concentration) in resected lung tissue and blood specimens from patients with respiratory tuberculosis treated with ultrasound inhalations of the drugs showed that their concentrations in the lungs were high and persisted at the minimum bacteriostatic level for 48 hours. Comparison of the drug levels in the lung tissue with those in the blood revealed correlation between the characteristics. It was most pronounced in 3 and 24 hours (the correlation coefficient ranged within 0.50-0.56). The moderate direct linear relation within the above period allowed one to perform preliminary theoretical estimation of the drug concentrations in the lung tissue using the regression equation and the values of the drug blood levels. The clinical trials (52 cases) showed coincidence of the theoretical estimation with the empirical findings. Therefore, the data of the study are of a practical value and may be used for correction of the therapy with streptomycin and isoniazid ultrasound inhalations, especially when Mycobacterium tuberculosis are resistant to the drugs.

摘要

相似文献

1
[Pharmacokinetic characteristics of streptomycin and isoniazid administered in ultrasonic aerosols to patients with respiratory organ tuberculosis].
Antibiotiki. 1981 Aug;26(8):628-32.
2
[Basis for the administration of streptomycin and isoniazid in ultrasonic aerosols in the treatment of intrathoracic tuberculosis].
Antibiotiki. 1977 May;22(5):469-71.
3
[Concentration of streptomycin and isoniazid in the blood of patients over 50 with pulmonary tuberculosis after administration of the drugs in ultrasonic aerosols].[50岁以上肺结核患者经超声雾化吸入给药后血液中链霉素和异烟肼的浓度]
Antibiotiki. 1982 Dec;27(12):53-6.
4
[Isoniazid concentrations in the blood, resected lung tissue and the gallbladder bed in relation to the method of administration to pulmonary tuberculosis patients with stomach and liver diseases].[与给药方法相关的肺结核合并胃和肝脏疾病患者血液、切除肺组织及胆囊床中的异烟肼浓度]
Antibiotiki. 1984 Sep;29(9):671-3.
5
[Effect of ultrasonic aerosols of streptomycin and isoniazid on the bronchial tree of patients with intrathoracic tuberculosis].
Probl Tuberk. 1984 Apr(4):53-5.
6
[Pharmacokinetics of isoniazid, rifampicin and streptomycin in tuberculosis patients with chronic cor pulmonale].[异烟肼、利福平及链霉素在慢性肺源性心脏病肺结核患者中的药代动力学]
Probl Tuberk. 1985(10):34-7.
7
[Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
Antibiotiki. 1984 Jun;29(6):430-4.
8
Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.印度古吉拉特邦既往治疗过的结核病患者的耐药性研究。
Int J Tuberc Lung Dis. 2002 Dec;6(12):1098-101.
9
[Effect of ultrasonic inhalations of antitubercular preparations on the air-blood barrier of the lung].[抗结核制剂超声雾化吸入对肺气血屏障的影响]
Probl Tuberk. 1985(4):48-51.
10
[Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations].[联合使用利福平与异烟肼治疗结核病时血液及切除肺组织中的药物浓度]
Probl Tuberk. 1980 Aug(8):63-5.